Healthtech Startups

Selera Medical develops a minimally invasive implantable device that treats heart failure by removing excess fluid buildup, reducing hospitalizations and symptom recurrence through a single procedure.

1 investor

Selfapy is a digital mental health platform offering prescription-covered online therapy programs in Germany. The platform provides structured psychological treatment for mental health conditions, accessible remotely without waitlists and monitored by clinical psychologists.

1 investor

Self Fund Health (SFH) offers a self-funded employer health plan built on Medicare-based reference pricing, with a preferred-provider "paved road" where members pay $0 and employers pay less than carrier markups. It targets employers and benefits brokers, providing tools like a Price Explorer, savings simulator, hospital report cards, nurse navigators, and transparent PEPM pricing without spread pricing or retained rebates.

1 investor

Selfiie is a health technology company focused on personal health records and health information exchange, positioned within the digital health and healthcare privacy space. Its founding team includes people involved in personal health records, health information exchange, encryption, and HIPAA health privacy rules.

1 investor

Semantix designs, builds, and operates AI-driven intelligent enterprises at scale, transforming complex business environments through orchestrated data, artificial intelligence, and enterprise operations. The platform serves large organizations seeking to evolve from traditional IT toward autonomous operations powered by intelligent agents and continuous optimization.

1 investor

Semler Scientific develops FDA-cleared medical devices for early detection of vascular diseases, particularly peripheral arterial disease, serving healthcare providers and patients. The company manufactures point-of-care diagnostic systems and related software platforms for arterial blood flow measurement.

1 investor

1 investor

Senecio Robotics builds an AI-powered platform that automates the Sterile Insect Technique (SIT) for mosquito control, using a production line that breeds, separates, sterilizes, and packages sterile male mosquitoes for release. It serves governments, public health organizations, and pest control companies aiming to suppress mosquito populations and reduce mosquito-borne diseases.

1 investor

Senex Biotechnology develops cancer and chronic disease therapies by targeting aging-related biological pathways identified through functional genomics. The company focuses on oncology indications including ovarian, breast, and prostate cancers.

1 investor

Senior Helpers provides in-home senior care across the United States, offering services from companion assistance with daily activities to specialized care for chronic conditions. It serves seniors and their families, including those with Alzheimer's, dementia, and Parkinson's disease.

1 investor

Senior Place provides software for home care agencies and senior placement professionals to manage client relationships, referrals, and workflows. The platform helps teams organize leads, track placements, and coordinate with referral partners.

1 investor

Careforth supports family caregivers who care for loved ones at home, providing coaching, care planning, community resources, and weekly payments through its Structured Family Caregiving service. The company serves family caregivers in the United States, with support offered in English, Spanish, and other languages.

1 investor

Senior Service provides non-medical home care and supplementary informal-care support for elderly people in the Netherlands, ranging from weekly companionship to 24-hour care, helping seniors continue living at home. It matches clients with fixed employed caregivers and coordinators, and advises on financing routes such as insurance, PGB, Wlz and Wmo.

1 investor

Seniovo, part of the HORNBACH group, provides barrier-free bathroom renovations and home modifications along with services such as emergency call systems, care aids, care consulting, and everyday assistance, many financeable through statutory subsidies. It serves elderly and mobility-limited individuals seeking to live independently in their own homes in Germany.

1 investor

Seno Medical develops the Imagio Breast Imaging System, an opto-acoustic ultrasound imaging modality for diagnosing breast cancer without needles, dyes, or ionizing radiation. It is aimed at radiologists, breast imaging staff, and healthcare systems to reduce false-positive biopsies and provide a simplified diagnostic pathway for patients.

1 investor

Senotherapeutix (d/b/a Gerotherapeutix) develops gerotherapeutics based on its MitoXcel geropeptide platform, which targets mitochondrial mechanisms of cellular aging to improve healthspan and extend lifespan. The company operates three subsidiaries spanning longevity therapeutics (Eos Senolytix), oncology peptides (Perseus Senolytix), and controllable gene therapies (Phoenix Senolytix).

1 investor

Sens.ai measures functional brain age using EEG+ERP assessments and provides personalized training programs to improve cognitive function. The company serves individuals seeking to optimize brain health and track neurological aging through daily 15-minute sessions.

1 investor

SensID GmbH develops and manufactures reference materials and quality controls for DNA diagnostics. The company serves laboratory and diagnostic instrument developers who need precisely characterized materials for research, validation, accreditation, and conformity testing.

1 investor

Sensars develops an implantable neurostimulation system that restores sensory feedback to the limbs by interfacing a proprietary intra-nerve electrode array with sensory nerve fibers, paired with wearable sensor insoles. The technology targets diabetic neuropathy and limb loss to reduce complications such as ulcers, falls, and amputations.

1 investor

Sense4Care develops wearable medical devices for movement disorder assessment, particularly Parkinson's Disease, using inertial measurement analysis. The company sells its STAT-ON product to hospitals, neurologists, and healthcare providers across Europe for objective symptom evaluation and disease management.

1 investor

Faeth Therapeutics is a biotech developing PIKTOR, an all-oral combination therapy that inhibits multiple nodes of the PAM (PI3K/AKT/mTOR) oncogenic pathway. It focuses on cancer treatments, with programs in endometrial cancer and HR+/HER2- breast cancer.

1 investor

Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.

1 investor

Sensentia provides data translation and decision-support software for health insurance, turning complex policy information into actionable answers for customer service representatives, brokers, and agents at the point of sale and service.

1 investor

Senseye develops technology and tools for detecting and treating PTSD, leveraging neuroscience research and machine learning. The company serves mental health practitioners and trauma patients in the healthcare sector.

1 investor